Bluejay Diagnostics Inc (BJDX)
$0.90
$-0.01
(-1.04%)
As on 28-Aug-2026 16:27EDT
Market cap
$1 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-0.1
-
Debt to Equity
0
-
Book Value
$4.7
-
EPS
$-12.6
-
Face value
--
-
Shares outstanding
1,034,715
5 Years Aggregate
CFO
$-22.62 Mln
EBITDA
$-24.32 Mln
Net Profit
$-24.79 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bluejay Diagnostics Inc (BJDX)
| -66.3 | -18.2 | -54.0 | -83.6 | -95.5 | -- | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Bluejay Diagnostics Inc (BJDX)
| -86.3 | -99.0 | -83.9 | -85.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bluejay Diagnostics Inc (BJDX)
|
0.9 | 0.9 | 0.0 | -7.3 | -- | -94.5 | -- | 0.1 |
| 61.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 321.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 176.3 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 | |
| 29.0 | 12,153.4 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.9 | 2.4 |
Shareholding Pattern
View DetailsAbout Bluejay Diagnostics Inc (BJDX)
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic... biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts. Read more
-
Principal Financial, Accounting & Executive Officer, President, CEO and Director
Mr. Indranil Dey
-
Principal Financial, Accounting & Executive Officer, President, CEO and Director
Mr. Indranil Dey
-
Headquarters
Acton, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Bluejay Diagnostics Inc (BJDX)
What is the current share price of Bluejay Diagnostics Inc (BJDX) Today?
The share price of Bluejay Diagnostics Inc (BJDX) is $0.90 (NASDAQ) as of 28-Aug-2026 16:27 EDT. Bluejay Diagnostics Inc (BJDX) has given a return of -95.53% in the last 3 years.
What is the current PB & PE ratio of Bluejay Diagnostics Inc (BJDX)?
Since, TTM earnings of Bluejay Diagnostics Inc (BJDX) is negative, P/E ratio is not available.
The P/B ratio of Bluejay Diagnostics Inc (BJDX) is 0.10 times as on 28-Aug-2026, a 97 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.04 |
0.05 |
2024 |
-0.03 |
0.03 |
2023 |
0.00 |
0.02 |
2022 |
0.00 |
0.00 |
2021 |
-0.02 |
0.00 |
What is the 52 Week High and Low of Bluejay Diagnostics Inc (BJDX)?
The 52-week high and low of Bluejay Diagnostics Inc (BJDX) are Rs 16.68 and Rs 0.83 as of 31-Aug-2026.
What is the market cap of Bluejay Diagnostics Inc (BJDX)?
Bluejay Diagnostics Inc (BJDX) has a market capitalisation of $ 1 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bluejay Diagnostics Inc (BJDX)?
Before investing in Bluejay Diagnostics Inc (BJDX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.